Cannara Biotech (TSXV:LOVE) EV-to-FCF : -568.21 (As of Jun. 09, 2024)

Cannara Biotech EV-to-FCF Chart

Cannara Biotech Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
EV-to-FCF	Get a 7-Day Free Trial															-6.47	-10.48	-29.68	-43.60	-693.49

Competitive Comparison of Cannara Biotech's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Cannara Biotech's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannara Biotech's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannara Biotech's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Cannara Biotech's EV-to-FCF falls into.

Cannara Biotech EV-to-FCF Calculation

Cannara Biotech's EV-to-FCF for today is calculated as:

Cannara Biotech's current Enterprise Value is C$110.23 Mil.
Cannara Biotech's Free Cash Flow for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannara Biotech  (TSXV:LOVE) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Cannara Biotech's PE Ratio for today is calculated as:

Cannara Biotech's share price for today is C$0.71.
Cannara Biotech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.060.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Cannara Biotech EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannara Biotech (TSXV:LOVE) Business Description